Related Experiment Video

Updated: May 6, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

26.7K

Hypersensitivity reactions associated with fidaxomicin use

Dmitri E Iarikov1, John Alexander, Sumathi Nambiar

  • 1Division of Anti-Infective Products, Food and Drug Administration, Silver Spring, Maryland.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|November 2, 2013
PubMed

Insights

Hypersensitivity reactions were reported with fidaxomicin, an antibiotic for C. difficile diarrhea. Despite minimal absorption, these severe reactions prompted labeling updates for patient safety.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Drug Safety

Background:

  • Fidaxomicin is an antibacterial agent used for Clostridium difficile-associated diarrhea.
  • Hypersensitivity reactions are a potential concern with pharmaceutical interventions.
  • The minimal absorption of fidaxomicin made hypersensitivity reactions unexpected.

Purpose of the Study:

  • To report and characterize hypersensitivity reactions associated with fidaxomicin use.
  • To highlight the clinical significance and unexpected nature of these adverse events.
  • To inform prescribing practices and patient monitoring.

Main Methods:

  • Case reporting and clinical observation of patients treated with fidaxomicin.
  • Review of adverse event data.
  • Analysis of drug absorption characteristics in relation to observed reactions.

Main Results:

  • Hypersensitivity reactions were identified in patients receiving fidaxomicin.
  • These reactions were considered severe.
  • The occurrence was unexpected given fidaxomicin's minimal systemic absorption.

Conclusions:

  • Fidaxomicin can cause hypersensitivity reactions, even with low absorption.
  • The severity necessitates awareness among healthcare providers.
  • Updated drug labeling is crucial for informed patient care and risk management.
Keywords:
adverse reactionsfidaxomicinhypersensitivity

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.7K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

8.4K

Related Concept Videos

Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
221
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
223
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
232
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
163
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
287
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K